Annual Cash & Cash Equivalents
$99.22 M
-$22.50 M-18.49%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual cash & cash equivalents is $99.22 million, with the most recent change of -$22.50 million (-18.49%) on December 31, 2023.
- During the last 3 years, XFOR annual cash & cash equivalents has risen by +$20.51 million (+26.06%).
- XFOR annual cash & cash equivalents is now -21.37% below its all-time high of $126.18 million, reached on December 31, 2019.
Performance
XFOR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$97.41 M
-$49.81 M-33.83%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly cash and cash equivalents is $97.41 million, with the most recent change of -$49.81 million (-33.83%) on September 30, 2024.
- Over the past year, XFOR quarterly cash and cash equivalents has dropped by -$49.81 million (-33.83%).
- XFOR quarterly cash and cash equivalents is now -33.83% below its all-time high of $147.22 million, reached on June 30, 2024.
Performance
XFOR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XFOR Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -18.5% | -33.8% |
3 y3 years | +26.1% | -33.8% |
5 y5 years | +222.6% | +27.8% |
XFOR Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -18.5% | +21.3% | -33.8% | +105.6% |
5 y | 5-year | -21.4% | +26.1% | -33.8% | +105.6% |
alltime | all time | -21.4% | +3169.1% | -33.8% | +3109.6% |
X4 Pharmaceuticals Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $97.41 M(-33.8%) |
Jun 2024 | - | $147.22 M(+143.4%) |
Mar 2024 | - | $60.49 M(-39.0%) |
Dec 2023 | $99.22 M(-18.5%) | $99.22 M(-24.6%) |
Sep 2023 | - | $131.58 M(-3.6%) |
Jun 2023 | - | $136.43 M(+46.1%) |
Mar 2023 | - | $93.41 M(-23.3%) |
Dec 2022 | $121.72 M(+48.8%) | $121.72 M(+52.4%) |
Sep 2022 | - | $79.86 M(+68.5%) |
Jun 2022 | - | $47.38 M(-28.7%) |
Mar 2022 | - | $66.43 M(-18.8%) |
Dec 2021 | $81.79 M(+3.9%) | $81.79 M(+7.1%) |
Sep 2021 | - | $76.39 M(-19.7%) |
Jun 2021 | - | $95.16 M(-17.2%) |
Mar 2021 | - | $114.94 M(+46.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $78.71 M(-37.6%) | $78.71 M(-11.4%) |
Sep 2020 | - | $88.81 M(-14.4%) |
Jun 2020 | - | $103.74 M(-9.8%) |
Mar 2020 | - | $115.05 M(-8.8%) |
Dec 2019 | $126.18 M(+310.3%) | $126.18 M(+65.5%) |
Sep 2019 | - | $76.25 M(-15.4%) |
Jun 2019 | - | $90.18 M(+304.4%) |
Mar 2019 | - | $22.30 M(-27.5%) |
Dec 2018 | $30.75 M(-60.0%) | $30.75 M(-24.5%) |
Sep 2018 | - | $40.75 M(-18.4%) |
Jun 2018 | - | $49.94 M(-22.0%) |
Mar 2018 | - | $64.00 M(-16.7%) |
Dec 2017 | $76.79 M(+2430.2%) | $76.79 M(+192.5%) |
Sep 2017 | - | $26.25 M(+765.0%) |
Dec 2016 | $3.04 M(-55.1%) | $3.04 M |
Dec 2015 | $6.76 M | - |
FAQ
- What is X4 Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is X4 Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is X4 Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of XFOR is $99.22 M
What is the all time high annual cash & cash equivalents for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual cash & cash equivalents is $126.18 M
What is X4 Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, XFOR annual cash & cash equivalents has changed by -$22.50 M (-18.49%)
What is X4 Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XFOR is $97.41 M
What is the all time high quarterly cash and cash equivalents for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly cash and cash equivalents is $147.22 M
What is X4 Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, XFOR quarterly cash and cash equivalents has changed by -$49.81 M (-33.83%)